References
- ZieglerDAmetovABarinovAOral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trialDiabetes Care200629112365237017065669
- ZieglerDLowPALitchyWJEfficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trialDiabetes Care20113492054206021775755
- PackerLWittEHTritschlerHJalpha-Lipoic acid as a biological antioxidantFree Radic Biol Med19951922272507649494
- BiewengaGVriesmannMFHaenenGRMMBastAThe identification of a new metabolite of lipoic acid in man: 3-ketolipoic acidBiewengaGLipoic Acid – A Pharmacochemical Study [thesis]Amsterdam, the NetherlandsVrije Universiteit1997137152
- RochetteLGhibuSRichardCZellerMCottinYVergelyCDirect and indirect antioxidant properties of α-lipoic acid and therapeutic potentialMol Nutr Food Res201357111412523293044
- HermannRNiebchGBorbeHOEnantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteersEur J Pharm Sci19964167174
- HermannRWildgrubeHJRuusPNiebchGNowakHGleiterCHGastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomersEur J Pharm Sci199861273716256705
- Breithaupt-GröglerKNiebchGSchneiderEDose-proportionality of oral thioctic acid – coincidence of assessments via pooled plasma and individual dataEur J Pharm Sci199981576510072479
- GleiterCHSchugBSHermannRElzeMBlumeHHGundert-RemyUInfluence of food intake on the bioavailability of thioctic acid enantiomersEur J Clin Pharmacol19965065135148858282
- GleiterCHSchreebKHFreudenthalerSLack of interaction between thioctic acid, glibenclamide and acarboseBr J Clin Pharmacol199948681982510594485
- TeichertJPreissRHigh-performance liquid chromatographic assay for alpha-lipoic acid and five of its metabolites in human plasma and urineJ Chromatogr B Analyt Technol Biomed Life Sci20027692269281
- TeichertJHermannRRuusPPreissRPlasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteersJ Clin Pharmacol200343111257126714551180
- TeichertJTuemmersTAchenbachHPharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal diseaseJ Clin Pharmacol200545331332815703366
- BöhmSWhat can oral thioctic therapy accomplish? Steadier plasma levels of thioctic acid with the help of a new oral formulation. MMW SpecialMünch med Wschr1999141Suppl15
- NiebchGBücheleBBlomeJEnantioselective high-performance liquid chromatography assay of (+)R- and (−)S-alpha-lipoic acid in human plasmaChirality19979132369094201
- SchugBSHermannRBlumeHHElzeMGender effect on the pharmacokinetics of thioctic acid: An evaluation of several bioavailability studiesNaunyn–Schmiedebergs Archives of Pharmacology1998357Suppl 4R4R4